A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Mitolyn is a new dietary supplement that recently hit the market, and is said to be the ultimate weight loss solution. The ...

The quest for effective weight-loss solutions is a journey many embark on, often seeking products that promise to accelerate ...

Losing weight isn’t as easy as taking a few magical pills. However, certain vitamins and minerals can help ensure your body is functioning as efficiently as possible for weight loss. A well ...

What if your doctor only looks at BMI? Some doctors will use BMI to assume ill health and prescribe weight loss, Stanford said. Stanford advises patients whose doctor only focuses on BMI to ...

The outlook cut comes as Eli Lilly competes with Novo Nordisk and other, smaller rivals for share of the exploding weight loss and diabetes drug market. Eli Lilly is developing an obesity pill ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13. The company is preparing to release key late ...

Separately, Eli Lilly said that it expects its new weight loss pill to be approved by U.S. regulators in 2026. The Indianapolis, Indiana-based company said that it will release late-stage trial ...